Endoscopic Balloon Therapy

Michael J. Klingler; Matthew Kroh

doi:10.1016/j.suc.2020.12.009

Endoscopic Balloon Therapy

Michael J. Klingler
, Matthew Kroh

Cleveland Clinic Abu Dhabi

Cleveland Clinic Foundation

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Intragastric balloon therapy is an endoluminal treatment of obesity that is indicated for patients with moderate obesity (body mass index, 30–35 kg/m²) who have failed to lose weight with lifestyle and medical management. Treatment duration ranges from 4 to 12 months, and percent total body weight loss ranges from 6% to 15% at the time of balloon removal. Adverse events, such as bowel obstruction or gastric perforation, are rare, and early balloon removal because of intolerance is the most common complication. Long-term data are lacking, although weight regain after balloon removal seems to be common.

Original language	English
Pages (from-to)	355-371
Number of pages	17
Journal	Surgical Clinics of North America
Volume	101
Issue number	2
DOIs	https://doi.org/10.1016/j.suc.2020.12.009
State	Published - Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Endoluminal bariatrics
Endoscopic bariatrics
Intragastric balloon

Access to Document

10.1016/j.suc.2020.12.009

Cite this

@article{7d4c3faed756498eae85b175c5771428,

title = "Endoscopic Balloon Therapy",

abstract = "Intragastric balloon therapy is an endoluminal treatment of obesity that is indicated for patients with moderate obesity (body mass index, 30–35 kg/m2) who have failed to lose weight with lifestyle and medical management. Treatment duration ranges from 4 to 12 months, and percent total body weight loss ranges from 6\% to 15\% at the time of balloon removal. Adverse events, such as bowel obstruction or gastric perforation, are rare, and early balloon removal because of intolerance is the most common complication. Long-term data are lacking, although weight regain after balloon removal seems to be common.",

keywords = "Endoluminal bariatrics, Endoscopic bariatrics, Intragastric balloon",

author = "Klingler, \{Michael J.\} and Matthew Kroh",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2021",

month = apr,

doi = "10.1016/j.suc.2020.12.009",

language = "English",

volume = "101",

pages = "355--371",

journal = "Surgical Clinics of North America",

issn = "0039-6109",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Endoscopic Balloon Therapy

AU - Klingler, Michael J.

AU - Kroh, Matthew

PY - 2021/4

Y1 - 2021/4

N2 - Intragastric balloon therapy is an endoluminal treatment of obesity that is indicated for patients with moderate obesity (body mass index, 30–35 kg/m2) who have failed to lose weight with lifestyle and medical management. Treatment duration ranges from 4 to 12 months, and percent total body weight loss ranges from 6% to 15% at the time of balloon removal. Adverse events, such as bowel obstruction or gastric perforation, are rare, and early balloon removal because of intolerance is the most common complication. Long-term data are lacking, although weight regain after balloon removal seems to be common.

AB - Intragastric balloon therapy is an endoluminal treatment of obesity that is indicated for patients with moderate obesity (body mass index, 30–35 kg/m2) who have failed to lose weight with lifestyle and medical management. Treatment duration ranges from 4 to 12 months, and percent total body weight loss ranges from 6% to 15% at the time of balloon removal. Adverse events, such as bowel obstruction or gastric perforation, are rare, and early balloon removal because of intolerance is the most common complication. Long-term data are lacking, although weight regain after balloon removal seems to be common.

KW - Endoluminal bariatrics

KW - Endoscopic bariatrics

KW - Intragastric balloon

UR - https://www.scopus.com/pages/publications/85102726545

U2 - 10.1016/j.suc.2020.12.009

DO - 10.1016/j.suc.2020.12.009

M3 - Review article

C2 - 33743974

AN - SCOPUS:85102726545

SN - 0039-6109

VL - 101

SP - 355

EP - 371

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

IS - 2

ER -

Endoscopic Balloon Therapy

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this